CONVERSION FROM ADVAGRAF OR PROGRAF TO ENVARSUS IN STABLE LUNG TRANSPLANT (LUTX) PATIENTS

被引：0

作者：

Kulu, A. ^{[1
]}

Stork, T. ^{[1
]}

Murakoezy, G. ^{[1
]}

Hielle-Wittmann, E. ^{[1
]}

Lambers, C. ^{[1
]}

Klepetko, W. ^{[1
]}

Jaksch, P. ^{[1
]}

机构：

[1] MUW, Thoraxchirug, Vienna, Austria

来源：

TRANSPLANT INTERNATIONAL | 2017年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

引用

页码：16 / 16

页数：1

共 50 条

[11] Lower Variability of Tacrolimus Trough Concentration After Conversion From Prograf to Advagraf in Stable Kidney Transplant Recipients [J].

Wu, Ming-Ju ;

Cheng, Ching-Yao ;

Chen, Cheng-Hsu ;

Wu, Wen-Pyng ;

Cheng, Chi-Hung ;

Yu, Dong-Ming ;

Chuang, Ya-Wen ;

Shu, Kuo-Hsiung .

TRANSPLANTATION, 2011, 92 (06) :648-652

[12] CONVERSION FROM TWICE-DAILY PROGRAF TO ONCE-DAILY ADVAGRAF IS STRAIGHTFORWARD IN STABLE LIVER TRANSPLANT RECIPIENTS [J].

Thorburn, D. ;

Paczek, L. ;

Wolf, P. ;

Boillot, O. .

TRANSPLANT INTERNATIONAL, 2009, 22 :211-211

[13] Clinical Impact of Conversion from Prograf to Advagraf in Simultaneous Kidney-Pancreas Transplant Recipients [J].

Falconer, S. J. ;

Oniscu, G. C. .

TRANSPLANTATION, 2012, 94 (10) :774-774

[14] Switching from Prograf® to Advagraf® in Stable Kidney Transplant Recipients-Do Asians Differ? [J].

Ramasamy, Dheepa ;

Wong, Hin Seng ;

Yakob, Suryati ;

Ideris, Khairiyah .

TRANSPLANTATION, 2018, 102 :S591-S591

[15] Conversion From Prograf to Advagraf Among Kidney Transplant Recipients Results in Sustained Decrease in Tacrolimus Exposure [J].

Hougardy, Jean-Michel ;

Broeders, Nilufer ;

Kianda, Mireille ;

Massart, Annick ;

Madhoun, Phillippe ;

Le Moine, Alain ;

Hoang, Anh-Dung ;

Mikhalski, Dimitri ;

Wissing, Karl M. ;

Abramowicz, Daniel .

TRANSPLANTATION, 2011, 91 (05) :566-569

[16] Conversion From Prograf to Advagraf in Stable Kidney Transplant Recipients: Better Renal Function After 3-Year Follow-up [J].

Spagnoletti, G. ;

Gargiulo, A. ;

Salerno, M. P. ;

Favi, E. ;

Pedroso, J. A. ;

Calia, R. ;

Romagnoli, J. ;

Citterio, F. .

TRANSPLANTATION PROCEEDINGS, 2014, 46 (07) :2224-2227

[17] Impact of the Conversion of the Immunosuppressive Regimen from Prograf to Advagraf or to Sirolimus in Long-term Stable Liver Transplant Recipients: Indications, Safety, and Outcome [J].

Perrakis, A. ;

Schwarz, K. ;

Yedibela, S. ;

Croner, R. S. ;

Hohenberger, W. ;

Mueller, V. .

TRANSPLANTATION PROCEEDINGS, 2011, 43 (10) :3702-3707

[18] Tacrolimus drug monitoring during conversion from very high dose Prograf® to Advagraf® in a kidney transplant recipient [J].

Boschi, C. ;

Legris, T. ;

Berard, C. ;

Quaranta, S. ;

Moal, V. ;

Daniel, L. ;

Lacarelle, B. ;

Manos, E. S. M. Sampol .

FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 :76-76

[19] Patients' Compliance and Drug Efficacy after Conversion from Prograf to Advagraf in Liver Transplantation Recipients [J].

Toti, Luca ;

Manzia, Tommaso M. ;

Anselmo, Alessandro ;

Perrone, Luciano ;

Angelico, Roberta ;

Tisone, Giuseppe .

LIVER TRANSPLANTATION, 2010, 16 (06) :S75-S75

[20] SAFE CONVERSION OF STABLE KIDNEY TRANSPLANT RECIPENTS FROM TWICE-DAILY TACROLIMUS (Prograf) TO ONCE-DAILY MODIFIED RELEASE TACROLIMUS (Advagraf) [J].

Carmellini, Mario ;

Ruggieri, Giuliana ;

Collini, Andrea .

TRANSPLANT INTERNATIONAL, 2011, 24 :283-283

← 1 2 3 4 5 →